BROHM; Dirk

Patent Applications and Registrations

Patent applications and USPTO patent grants for BROHM; Dirk.The latest application filed is for "disubstituted benzothienyl-pyrrolotriazines and their use as fgfr kinase inhibitors".

Company Profile

4.9.17

BROHM; Dirk - Mettmann DE
Brohm; Dirk - Herdecke N/A DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Disubstituted Benzothienyl-pyrrolotriazines And Their Use As Fgfr Kinase Inhibitors App 20220153745 - BROHM; Dirk ; et al.	2022-05-19
Process For Preparing 2,6-dialkylphenylacetic Acids App 20210403406 - HIMMLER; Thomas ; et al.	2021-12-30
Method for preparing 3-substituted 2-vinylphenyl sulfonates Grant 10,647,667 - Gallenkamp , et al.	2020-05-12
Method For Preparing 3-substituted 2-vinylphenyl Sulfonates App 20200071267 - GALLENKAMP; Daniel ; et al.	2020-03-05
Disubstituted Benzothienyl-pyrrolotriazines And Their Use As Fgfr Kinase Inhibitors App 20190016724 - BROHM; Dirk ; et al.	2019-01-17
Method for preparing 4-cyanopiperidine hydrochloride Grant 10,150,731 - Himmler , et al. Dec	2018-12-11
Process For The Preparation Of 5-amino-quinolin-2(1h)-ones And Their Tautomer Forms 5-amino-quinolin-2-ols App 20180230101 - MUEHLTHAU; Friedrich August ; et al.	2018-08-16
Substituted pyridobenzodiazepinone-derivatives and use thereof Grant 10,047,096 - Schall , et al. August 14, 2	2018-08-14
Method For Preparing 4-cyanopiperidine Hydrochloride App 20170369442 - HIMMLER; THOMAS ; et al.	2017-12-28
Substituted Pyridobenzodiazepinone-derivatives And Use Thereof App 20170253602 - SCHALL; Andreas ; et al.	2017-09-07
Chiral 2,5-disubstituted Cyclopentanecarboxylic Acid Derivatives And Use Thereof App 20170119776 - BECK; Hartmut ; et al.	2017-05-04
Heterobicyclically Substituted 4-oxobutane Acid Derivatives And Use Thereof App 20170121315 - BECK; Hartmut ; et al.	2017-05-04
2,5-disubstituted Cyclopentane Carboxylic Acids For The Treatment Of Respiratory Tract Diseases App 20170114049 - BECK; Hartmut ; et al.	2017-04-27
Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer Grant 9,598,416 - Collin , et al. March 21, 2	2017-03-21
2,5-disubstituted Cyclopentanecarboxylic Acids And Their Use App 20170022171 - BECK; Hartmut ; et al.	2017-01-26
Substituted benzothienyl-pyrrolotriazines and uses thereof Grant 9,475,815 - Lobell , et al. October 25, 2	2016-10-25
Disubstituted benzothienyl-pyrrolotriazines and uses thereof Grant 9,206,184 - Brohm , et al. December 8, 2	2015-12-08
Substituted Benzothienyl - Pyrrolotriazines And Uses Thereof In The Treatment Cancer App 20150080371 - Collin; Marie-Pierre ; et al.	2015-03-19
Substituted Benzothienyl-pyrrolotriazines And Uses Thereof App 20150031676 - Lobell; Mario ; et al.	2015-01-29
Disubstituted Benzothienyl-pyrrolotriazines And Their Use As Fgfr Kinase Inhibitors App 20140336173 - Brohm; Dirk ; et al.	2014-11-13
Substituted phenylaminothiazoles and use thereof Grant 8,691,850 - Erguden , et al. April 8, 2	2014-04-08
Disubstituted benzothienyl-pyrrolotriazines and uses thereof App 20130158000 - BROHM; Dirk ; et al.	2013-06-20
Sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors Grant 8,003,787 - Eis , et al. August 23, 2	2011-08-23
Novel Sulphoximine-substituted Quinoline And Quinazoline Derivatives As Kinase Inhibitors App 20090226377 - EIS; Knut ; et al.	2009-09-10
Substituted Phenylaminothiazoles and Use Thereof App 20080269300 - Erguden; Jens-Kerim ; et al.	2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.